Reports Q4 revenue $12.68M, consensus $12.47M. “The fourth quarter was a solid end to a strong year for Augmedix both operationally and financially,” stated Augmedix CEO Manny Krakaris. “We delivered a 45% increase in revenue to $12.7 million, ahead of our most recent guidance, driven by a 44% increase in clinicians in service and net revenue retention of 152%. Additionally, we made steady progress toward our profitability goals by increasing gross profit by 54% to $6.2 million, a margin expansion of 300 basis points to 49.3%, which contributed to the reduction in our operating cash burn.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AUGX:
- AUGX Earnings this Week: How Will it Perform?
- Augmedix announces data, product enhancements for Augmedix Go
- Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go
- Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
- Augmedix to Participate in Citizens JMP Technology Conference
